Dermira, Inc. announced the appointment of Lori Lyons-Williams as Chief Commercial Officer. In this new role, Lori will be responsible for developing and implementing the commercial strategy for Dermira’s Phase 3 product candidates: CIMZIA® (certolizumab pegol), in development in collaboration with UCB Pharma S.A. Prior to joining Dermira, she spent 15 years in positions of increasing responsibility within the sales and marketing organization at Allergan, most recently as Vice President, Sales & Marketing for the Urology franchise.